Partial deletion of the ALK gene in ALK‐positive anaplastic large cell lymphoma

E-ISSN： 1099-1069|36|1|150-158

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 150-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer

Current Medicinal Chemistry, Vol. 24, Iss. 6, 2017-03 ,pp. : 590-613

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of the Clinical and Immunohistochemical Features, Including Anaplastic Lymphoma Kinase (ALK) and p53, in Inflammatory Myofibroblastic Tumours

By Jiang You-Hua Cheng Bo Ge Ming-Hua Cheng Ye Zhang Gu

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 867-877

Field House Publishing

Access to resources Recommend Favorite

Methotrexate: Anaplastic large cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

Autologous Peripheral Stem-cell Transplantation after Intensive Chemotherapy in a Case of CD30 (Ki-1)-Positive Anaplastic Large-cell Lymphoma

By Tsuda T Matsunami M Nakayama K Hara J Sakaguchi R Katayama N Okamoto Y Ota K

The Journal of International Medical Research, Vol. 29, Iss. 5, 2001-09 ,pp. : 425-431

Field House Publishing

Access to resources Recommend Favorite

ALK-positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options

By Steuer Conor E. Ramalingam Suresh S.

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2392-2402

Blackwell Publishing

Access to resources Recommend Favorite